{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:58:39Z","timestamp":1767664719056,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"POR Campania FESR 2014-2020","award":["CUP B63D18000380007"],"award-info":[{"award-number":["CUP B63D18000380007"]}]},{"name":"RARE.PLAT.NET","award":["CUP B63D18000380007"],"award-info":[{"award-number":["CUP B63D18000380007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: Large Cell Neuroendocrine Carcinoma (LCNEC) is a rare subtype of lung cancer with poor clinical outcomes. Data on recurrence-free survival (RFS) in early and locally advanced pure LCNEC after complete resection (R0) are lacking. This study aims to evaluate clinical outcomes in this subgroup of patients and to identify potential prognostic markers. Methods: Retrospective multicenter study including patients with pure LCNEC stage I-III and R0 resection. Clinicopathological characteristics, RFS, and disease-specific survival (DSS) were evaluated. Univariate and multivariate analyses were performed. Results: 39 patients (M:F = 26:13), with a median age of 64 years (44\u201383), were included. Lobectomy (69.2%), bilobectomy (5.1%), pneumonectomy (18%), and wedge resection (7.7%) were performed mostly associated with lymphadenectomy. Adjuvant therapy included platinum-based chemotherapy and\/or radiotherapy in 58.9% of cases. After a median follow-up of 44 (4\u2013169) months, the median RFS was 39 months with 1-, 2- and 5-year RFS rates of 60.0%, 54.6%, and 44.9%, respectively. Median DSS was 72 months with a 1-, 2- and 5-year rate of 86.8, 75.9, and 57.4%, respectively. At multivariate analysis, age (cut-off 65 years old) and pN status were independent prognostic factors for both RFS (HR = 4.19, 95%CI = 1.46\u201312.07, p = 0.008 and HR = 13.56, 95%CI 2.45\u201374.89, p = 0.003, respectively) and DSS (HR = 9.30, 95%CI 2.23\u201338.83, p = 0.002 and HR = 11.88, 95%CI 2.28\u201361.84, p = 0.003, respectively). Conclusion: After R0 resection of LCNEC, half of the patients recurred mostly within the first two years of follow-up. Age and lymph node metastasis could help to stratify patients for adjuvant therapy.<\/jats:p>","DOI":"10.3390\/jpm13020330","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T02:01:10Z","timestamp":1676426470000},"page":"330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-3249","authenticated-orcid":false,"given":"Barbara","family":"Altieri","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-8657","authenticated-orcid":false,"given":"Anna","family":"La Salvia","sequence":"additional","affiliation":[{"name":"National Center for Drug Research and Evaluation, National Institute of Health (ISS), 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3768-5803","authenticated-orcid":false,"given":"Roberta","family":"Modica","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Marciello","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Mercier","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and Heart and Lung Transplantation, Universit\u00e9 Paris-Saclay, Marie Lannelongue Hospital, GHPSJ, 92350 Le Plessis Robinson, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Filosso","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, University of Turin, San Giovanni Battista Hospital, 10126 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand Richard","family":"de Latour","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Hospital Rennes Pontchaillou, University of Rennes, 422931 Rennes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-2304","authenticated-orcid":false,"given":"Dario","family":"Giuffrida","sequence":"additional","affiliation":[{"name":"Clinical Oncology Unit, Department of Experimental Oncology, Mediterranean Institute of Oncology, 95029 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severo","family":"Campione","sequence":"additional","affiliation":[{"name":"Department of Advanced Technology, Pathology Unit, Cardarelli Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Guggino","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Cardarelli Hospital, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-4589","authenticated-orcid":false,"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and Heart and Lung Transplantation, Universit\u00e9 Paris-Saclay, Marie Lannelongue Hospital, GHPSJ, 92350 Le Plessis Robinson, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-1700","authenticated-orcid":false,"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[{"name":"Department of Oncology, Pathology Unit, University of Turin, 10126 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-6823","authenticated-orcid":false,"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institute Gustave Roussy, Universit\u00e9 Paris Saclay, 94805 Villejuif, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[{"name":"Endocrine Oncology and Nuclear Medicine Department, Institute Gustave Roussy, Paris-Saclay University, 94805 Villejuif, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9324-3946","authenticated-orcid":false,"given":"Antongiulio","family":"Faggiano","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant\u2019Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/JTO.0000000000000589","article-title":"Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy","volume":"10","author":"Fasano","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/13993003.00618-2015","article-title":"Clinical features of large cell neuroendocrine carcinoma: A population-based overview","volume":"47","author":"Derks","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.cllc.2019.07.011","article-title":"Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study","volume":"21","author":"Kinslow","year":"2020","journal-title":"Clin. Lung Cancer."},{"key":"ref_4","unstructured":"France, L. (2021). Classification of Tumours: Thoracic Tumours."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.21037\/jtd.2020.01.07","article-title":"Prognostic markers in resected large cell neuroendocrine carcinoma: A multicentre retrospective analysis","volume":"12","author":"Roesel","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.athoracsur.2019.03.053","article-title":"Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis","volume":"108","author":"Raman","year":"2019","journal-title":"Ann. Thorac. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lungcan.2006.03.007","article-title":"Large cell neuroendocrine carcinoma of the lung: A retrospective analysis of 144 surgical cases","volume":"53","author":"Veronesi","year":"2006","journal-title":"Lung Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00268-017-3908-8","article-title":"Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma","volume":"41","author":"Kim","year":"2017","journal-title":"World J. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101728","DOI":"10.1016\/j.suronc.2022.101728","article-title":"Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinoma","volume":"41","author":"Soldath","year":"2022","journal-title":"Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lowczak, A., Kolasinska-Cwikla, A., Osowiecka, K., Glinka, L., Palucki, J., Rzepko, R., Doboszynska, A., and Cwikla, J.B. (2021). Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage. Medicina, 57.","DOI":"10.3390\/medicina57020118"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","article-title":"Early and locally advanced non-small-cell lung cancer: An update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"591823","DOI":"10.3389\/fonc.2021.591823","article-title":"Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma","volume":"11","author":"Peng","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jtcvs.2008.12.037","article-title":"Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma","volume":"138","author":"Iyoda","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3857\/roj.2021.00423","article-title":"Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung","volume":"39","author":"Moon","year":"2021","journal-title":"Radiat. Oncol. J."},{"key":"ref_17","first-page":"339","article-title":"Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: Results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database","volume":"52","author":"Filosso","year":"2017","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/CAD.0b013e328330fd79","article-title":"Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy","volume":"21","author":"Saji","year":"2010","journal-title":"Anticancer. Drugs"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtho.2018.01.019","article-title":"The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung","volume":"13","author":"Kujtan","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.athoracsur.2006.05.109","article-title":"Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma","volume":"82","author":"Iyoda","year":"2006","journal-title":"Ann. Thorac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s00268-019-04951-x","article-title":"Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long-Term Outcomes After R0 Resection","volume":"43","author":"Cattoni","year":"2019","journal-title":"World J. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0003-4975(03)01294-3","article-title":"The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung","volume":"77","author":"Casali","year":"2004","journal-title":"Ann. Thorac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2147\/OTT.S83347","article-title":"Clinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma","volume":"8","author":"Zhang","year":"2015","journal-title":"Onco. Targets Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"556194","DOI":"10.3389\/fonc.2020.556194","article-title":"Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy","volume":"10","author":"Shen","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1002\/cncr.24320","article-title":"A uniform residual tumor (R) classification: Integration of the R classification and the circumferential margin status","volume":"115","author":"Wittekind","year":"2009","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s12020-021-02869-w","article-title":"Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors","volume":"75","author":"Altieri","year":"2021","journal-title":"Endocrine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Barrea, L., Altieri, B., Muscogiuri, G., Laudisio, D., Annunziata, G., Colao, A., Faggiano, A., and Savastano, S. (2018). Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness. Nutrients, 10.","DOI":"10.3390\/nu10121854"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12020-020-02331-3","article-title":"Epidemiology of pancreatic neuroendocrine neoplasms: A gender perspective","volume":"69","author":"Muscogiuri","year":"2020","journal-title":"Endocrine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"649496","DOI":"10.3389\/fendo.2021.649496","article-title":"Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors","volume":"12","author":"Barrea","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.12659\/MSM.914541","article-title":"Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database","volume":"25","author":"Deng","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13023-021-01730-7","article-title":"Survival outcomes of surgery in patients with pulmonary large-cell neuroendocrine carcinoma: A retrospective single-institution analysis and literature review","volume":"16","author":"Chen","year":"2021","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Altieri, B., Di Dato, C., Martini, C., Sciammarella, C., Di Sarno, A., Colao, A., Faggiano, A., and Group, N. (2019). Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management. Cancers, 11.","DOI":"10.3390\/cancers11091332"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lowczak, A., Kolasinska-Cwikla, A., Cwikla, J.B., Osowiecka, K., Palucki, J., Rzepko, R., Glinka, L., and Doboszynska, A. (2020). Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051370"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.21037\/tcr-20-780","article-title":"Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma","volume":"9","author":"Xi","year":"2020","journal-title":"Transl. Cancer Res."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/2\/330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:35:54Z","timestamp":1760121354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/2\/330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["jpm13020330"],"URL":"https:\/\/doi.org\/10.3390\/jpm13020330","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}